
The Effect of Elective Sham Dose Escalation on the Placebo Response During an Antimuscarinic Trial for Overactive Bladder Symptoms
Keywords: مثانه ادرار; urinary bladder; overactive; fesoterodine; muscarinic antagonists; placebo effect; dose-response relationship; drug; AE; adverse event; OAB; overactive bladder; PBO; placebo; PBO-E; placebo escalator group; PBO-NE; placebo nonescalator group; PPBC; Patien